Oberhaching, April 2022
Dear Sir or Madam,
Today, we are informing you about a personnel change at Bendalis GmbH and Lyomark Pharma GmbH.
Mr Parvany will leave the companies on 31 March 2022. Mr Parvany had been active in both companies since 2012, initially as Head of Sales and Marketing and since 2017 as Managing Director.
We would like to take this opportunity to thank Mr. Parvany most sincerely for his great commitment over the past few years, which has significantly contributed to the company's success. We wish him all the best for the future.
From 1 April 2022, Dr. Dirk Hütten will join the management team alongside Dr. Burger. Dr. Hütten has over 20 years of experience in various international sales roles across the pharmaceutical product supply chain.
We are delighted that we have been able to secure Dr. Dirk Hütten as Managing Director and wish him every success.
The shareholders of Lyomark Pharma GmbH and Bendalis GmbH